AI In Pharmacovigilance Training Scheduled For May 17, 2027, Introducing AI Solutions For Adverse Event Detection, Reporting And Drug Safety Monitoring
Dublin, Nov. 18, 2026 (GLOBE NEWSWIRE) -- "AI in Pharmacovigilance (May 17, 2027)" has been added to ResearchAndMarkets.com's offering.
Research and Markets has opened registration for“AI in Pharmacovigilance”, a three-hour online course organised by IPI Academy. It takes place live on May 17, 2027. The course gives a comprehensive introduction to the impact of artificial intelligence on drug safety and monitoring. Participants will come away understanding the AI solutions available for pharmacovigilance practice.
Key Event Facts
- Course: AI in Pharmacovigilance Date: May 17, 2027 Time: 09:00-12:30 (GMT+1) Format: Live online, three hours CPD: 3 hours Speaker: Graeme Ladds, Director, PharSafer
What the Course Covers
The session opens with an introduction to the basics of AI. It then examines how AI is being applied to adverse event detection and reporting, and its role in drug discovery and drug repurposing. Participants explore the ethical considerations and regulatory landscape surrounding AI in pharmacovigilance. The course closes with future trends and innovations.
Why You Should Attend
- Build a working understanding of AI fundamentals as they apply to drug safety See how AI supports adverse event detection and reporting Understand AI's role in drug discovery and drug repurposing Review the ethical considerations and regulatory landscape for AI in pharmacovigilance Learn about future trends from a speaker with over 30 years in pharmacovigilance, while earning 3 CPD hours
Who Should Attend
- Pharmacovigilance specialists Drug safety officers Regulatory affairs professionals Clinical research associates Medical affairs personnel Data scientists working in healthcare and pharmaceuticals
Featured Speaker
- Graeme Ladds, Director, PharSafer. He has over 30 years of experience in the pharmaceutical industry. He began in 1989 as Head of Drug Safety & Medical Information at Ashbourne Pharmaceuticals and went on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals. He founded PharSafer Associates Ltd, a consultancy and specialist contract research organisation, and has been involved in medical device monitoring since 1994.
The course takes place on May 17, 2027. Drug safety and pharmacovigilance professionals exploring AI can review the programme and register their interest through Research and Markets.
For more information about this training visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment